Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Puiggros, Anna|||0000-0001-9627-4978
  • Baliakas, Panagiotis|||0000-0002-5634-7156
  • Athanasiadou, Anastasia
  • García-Malo, MaDolores
  • Collado, Rosa|||0000-0002-8205-6192
  • Xochelli, Aliki
  • Rodríguez-Rivera, María
  • Ortega, Margarita
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Luño, Elisa
  • Vargas, MªTeresa
  • Grau Cat, Javier
  • Martínez-Laperche, Carolina
  • Valiente, Alberto
  • Cervera, José|||0000-0001-8252-1106
  • Anagnostopoulos, Achilles|||0000-0003-4384-9031
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Stalika, Evangelia
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Robles, Diego
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Ivars, David
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Stamatopoulos, Kostas|||0000-0001-8529-640X
  • Espinet Solà, Blanca|||0000-0002-4294-8145
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53 abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53 abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, ≥3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53 abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

  • Puiggros, Anna|||0000-0001-9627-4978
  • Collado, Rosa|||0000-0002-8205-6192
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Ortega, Margarita
  • Ruiz-Xivillé, Neus
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Luño, Elisa
  • González, Teresa
  • Navarro, Blanca
  • García-Malo, MaDolores
  • Valiente, Alberto
  • Hernández, José Ángel
  • Ardanaz, María Teresa
  • Piñan, María Ángeles
  • Blanco, María Laura
  • Hernández-Sánchez, María|||0000-0001-9968-2782
  • Batlle Lopez, Ana|||0000-0003-4143-9020
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Salido, Marta|||0000-0001-9988-5977
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Terol, María José
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Costa, Dolors|||0000-0002-8276-3292
  • Moreno, Carol|||0000-0003-3275-0271
  • Carbonell, Félix
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Delgado, Julio|||0000-0002-5157-4376
  • Espinet i Solà, Blanca
Genomic complexity identified by chromosome banding analysis (CBA) predicts a worse clinical outcome in CLL patients treated either with standard or new treatments. Herein, we analyzed the clinical impact of complex karyotypes (CK) with or without high-risk FISH deletions (ATM and/or TP53, HR-FISH) in a cohort of 1045 untreated MBL/CLL patients. In all, 99/1045 (9.5%) patients displayed a CK. Despite ATM and TP53 deletions were more common in CK (25% vs 7%; P < 0.001; 40% vs 5%; P < 0.001, respectively), only 44% (40/90) patients with TP53 deletions showed a CK. CK group showed a significant higher two-year cumulative incidence of treatment (48% vs 20%; P < 0.001), as well as a shorter overall survival (OS) (79 mo vs not reached; P < 0.001). When patients were categorized regarding CK and HR-FISH, those with both characteristics showed the worst median OS (52 mo) being clearly distinct from those non-CK and non-HR-FISH (median not reached), but no significant differences were detected between cases with only CK or HR-FISH. Both CK and TP53 deletion remained statistically significant in the multivariate analysis for OS. In conclusion, CK group is globally associated with advanced disease and poor prognostic markers. Further investigation in larger cohorts with CK lacking HR-FISH is needed to elucidate which mechanisms underlie the poor outcome of this subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage - The PISCINA2 Study

  • Font Ribera, Laia|||0000-0001-8447-4905
  • Marco, Esther
  • Grimalt, Joan|||0000-0002-7391-5768
  • Pastor Benito, Susana|||0000-0003-2454-5163
  • Marcos, Ricard|||0000-0001-7891-357X
  • Abramsson-Zetterberg, Lilianne
  • Pedersen, Marie
  • Grummt, Tamara
  • Junek, Ralf
  • Barreiro, Esther|||0000-0003-2708-3443
  • Heederik, Dick
  • Spithoven, Jack
  • Critelli, Rossana
  • Naccarati, Alessio
  • Schmalz, Christina
  • Zwiener, Christian
  • Liu, Jiaqi
  • Zhang, Xiangru
  • Mitch, William
  • Gracia-Lavedan, Esther
  • Arjona, Lourdes
  • De Bont, Jeroen|||0000-0001-9924-5961
  • Tarès, Lluïsa
  • Vineis, Paolo
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Villanueva, Cristina|||0000-0002-0783-1259
Background: Swimming in pools is a healthy activity that entails exposure to disinfection by-products (DBPs), some of which are irritant and genotoxic. Objectives: We evaluated exposure to DBPs during swimming in a chlorinated pool and the association with short-term changes in genotoxicity and lung epithelium permeability biomarkers. Methods: Non-smoker adults (N = 116) swimming 40 min in an indoor pool were included. We measured a range of biomarkers before and at different times after swimming: trihalomethanes (THMs) in exhaled breath (5 min), trichloroacetic acid (TCAA) in urine (30 min), micronuclei in lymphocytes (1 h), serum club cell protein (CC16) (1 h), urine mutagenicity (2 h) and micronuclei in reticulocytes (4 days in a subset, N = 19). Several DBPs in water and trichloramine in air were measured, and physical activity was extensively assessed. We estimated interactions with polymorphisms in genes related to DBP metabolism. Results: Median level of chloroform, brominated and total THMs in water was 37.3, 9.5 and 48.5, μg/L, respectively, and trichloramine in air was 472.6 μg/m. Median exhaled chloroform, brominated and total THMs increased after swimming by 10.9, 2.6 and 13.4, μg/m, respectively. Creatinine-adjusted urinary TCAA increased by 3.1 μmol/mol. Micronuclei in lymphocytes and reticulocytes, urine mutagenicity and serum CC16 levels remained unchanged after swimming. Spearman correlation coefficients showed no association between DBP exposure and micronuclei in lymphocytes, urine mutagenicity and CC16. Moderate associations were observed for micronuclei in reticulocytes and DBP exposure. Conclusions: The unchanged levels of the short-term effect biomarkers after swimming and null associations with personal estimates of exposure to DBPs suggest no measurable effect on genotoxicity in lymphocytes, urine mutagenicity and lung epithelium permeability at the observed exposure levels. The moderate associations with micronuclei in reticulocytes require cautious interpretation given the reduced sample size.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic accuracy of non-melanocytic pink flat skin lesions on the legs, Dermoscopic and reflectance confocal microscopy evaluation

  • Gómez Martín, Ignacio
  • Moreno Fernández, Sara
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Segura, Sonia|||0000-0003-0653-1382
Pink flat skin lesions on the legs in elderly people represent a diagnostic challenge due to the paucity of clinical and dermoscopic evidence. A prospective study of 114 pink flat lesions on the legs of 85 elderly patients was performed to describe the utility of reflectance confocal microscopy in this clinical context. Evaluation of clinical, dermoscopic and confocal parameters and calculation of diagnostic accuracy/sensi-tivity/specificity for non-melanoma skin cancer diagnosis of each technique were carried out. Thirty-four benign and 80 malignant neoplasms were analysed. A correct clinical diagnosis was established in 49.1% of cases (sensitivity 68.7%, specificity 73.5%). Dermoscopy achieved 59.6% correct diagnosis (sensiti-vity 85%, specificity 67.6%) and confocal microscopy evaluation after clinical and dermoscopic evaluation rendered a correct diagnosis in 85.1% of cases (sensi-tivity 97.5%, specificity 88.2%). Confocal microscopy may improve diagnostic accuracy, sensitivity and specificity as a secondary evaluation after dermoscopy. A diagnostic confocal algorithm for pink flat lesions on the legs is proposed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma

  • Gallardo, Fernando|||0000-0002-8996-3828
  • Bertran, Joan
  • López-Arribillaga, Erika|||0000-0002-9451-6635
  • González, Jéssica
  • Menéndez, Silvia
  • Sánchez, Ignacio
  • Colomo, Luis|||0000-0001-5236-5085
  • Iglesias, Mar|||0000-0002-2274-4671
  • Garrido, Marta
  • Santamaría-Babí, Luis Francisco
  • Torres, Ferran|||0000-0002-7355-7913
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Cutaneous T-cell lymphomas (CTCLs) represent different subtypes of lymphoproliferative disorders with no curative therapies for the advanced forms of the disease (namely mycosis fungoides and the leukemic variant, Sézary syndrome). Molecular events leading to CTCL progression are heterogeneous, however recent DNA and RNA sequencing studies highlighted the importance of NF-κB and β-catenin pathways. We here show that the kinase TAK1, known as essential in B-cell lymphoma, is constitutively activated in CTCL cells, but tempered by the MYPT1/PP1 phosphatase complex. Blocking PP1 activity, both pharmacologically and genetically, resulted in TAK1 hyperphosphorylation at residues T344, S389, T444, and T511, which have functional impact on canonical NF-κB signaling. Inhibition of TAK1 precluded NF-κB and β-catenin signaling and induced apoptosis of CTCL cell lines and primary Sézary syndrome cells both in vitro and in vivo. Detection of phosphorylated TAK1 at T444 and T344 is associated with the presence of lymphoma in a set of 60 primary human samples correlating with NF-κB and β-catenin activation. These results identified TAK1 as a potential biomarker and therapeutic target for CTCL therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

B Cells and Tertiary Lymphoid Structures Influence Survival in Lung Cancer Patients with Resectable Tumors

  • Tang, Jun
  • Curull Serrano, Víctor|||0000-0003-2709-7431
  • Wang, Xuejie|||0000-0003-1398-3942
  • Mateu-Jiménez, Mercé
  • Pijuan, Lara|||0000-0002-9978-6933
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Qin, Liyun
  • Rodríguez-Fuster, Alberto|||0000-0002-4900-6126
  • Aguiló Espases, Rafael
  • Barreiro, Esther|||0000-0003-2708-3443
  • Ramis-Cabrer, Daniel|||0000-0001-7793-773X
Immune profile of B and T cells and tertiary lymphoid structures (TLSs) may differ in tumors of lung cancer (LC) patients with/without chronic obstructive pulmonary disease (COPD), and may also influence patient survival. We sought to analyze: (1) TLSs, germinal centers (GCs), B and T cells, and (2) associations of the immune biomarkers with the patients' 10-year overall survival (OS). TLSs (numbers and area), B [cluster of differentiation (CD) 20], and T (CD3), and GCs cells were identified in both tumor and non-tumor specimens (thoracotomy) from 90 LC-COPD patients and 43 LC-only patients. Ten-year OS was analyzed in the patients. Immune profile in tumors of LC-COPD versus LC: TLS numbers and areas significantly decreased in tumors of LC-COPD compared to LC patients. No significant differences were observed in tumors between LC-COPD and LC patients for B or T cells. Immune profile in tumors versus non-tumor specimens: TLS areas and B cells significantly increased, T cells significantly decreased in tumors of both LC and LC-COPD patients. Survival: in LC-COPD patients: greater area of TLSs and proportion of B cells were associated with longer survival rates. The immune tumor microenvironment differs in patients with underlying COPD and these different phenotypes may eventually impact the response to immunotherapy in patients with LC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome

  • Prasad, Aparna|||0000-0002-6786-2313
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Zapata Fenor, Luis|||0000-0003-4829-8363
  • Puiggros, Anna|||0000-0001-9627-4978
  • Melero, Carme
  • Puig, Anna
  • Sarria-Trujillo, Yaris|||0000-0003-2667-4372
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Garcia Muret, Maria Pilar|||0000-0003-1714-5815
  • Estrach, Teresa|||0000-0002-4601-2811
  • Servitje, Octavio|||0000-0002-9910-9617
  • Lopez-Lerma, Ingrid|||0000-0002-7690-8926
  • Gallardo, Fernando|||0000-0002-8996-3828
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Estivill, Xavier|||0000-0002-0723-2256
Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome. We have discovered genes that could be involved in the pathogenesis of Sézary syndrome. Some of the genes that are affected by somatic point mutations include ITPR1, ITPR2, DSC1, RIPK2, IL6, and RAG2, with some of them mutated in more than one patient. We observed several somatic copy number variations shared between patients, including deletions and duplications of large segments of chromosome 17. Genes with potential function in the T-cell receptor signaling pathway and tumorigenesis were disrupted in Sézary syndrome patients, for example, CBLB, RASA2, BCL7C, RAMP3, TBRG4, and DAD1. Furthermore, we discovered several fusion events of interest involving RASA2, NFKB2, BCR, FASN, ZEB1, TYK2, and SGMS1. Our work has implications for the development of potential therapeutic approaches for this aggressive disease.